HPV Vaccines: Questions Posed to British Parliament

[SaneVax: Citizens from around the globe are questioning the sanity of HPV vaccination programs. Britain is no exception. The Countess of Mar recently posed several questions about Gardasil and Cervarix to the British Parliament. Earl Howe, Under-Secretary of State, Department of Health responded in writing. Unfortunately, his responses included no scientific documentation or references to back up his statements. This is not acceptable. Medical consumers throughout the United Kingdom deserve more than public-relations sound bites. These questions are not going away. These questions deserve scientifically prove answers. Government health authorities have a responsibility to provide  answers along with adequate scientific documentation. Anything less is a violation of the public trust.]

HPV Vaccine Questioned in English Parliament

Posted on November 15, 2012 by ChildHealthSafety

House of Lords – Written Answers – Hansard Monday 5 November 2012

Health: Human Papillomavirus Vaccination

Safe?

Questions Asked by The Countess of Mar:

To ask Her Majesty’s Government whether they will review their policy on the use of the human papillomavirus vaccination (HPV) in the light of the recent research by Tomljenovic and Shaw about the safety of HPV.[HL2911]

[ED: The research abstract is found here: Death after Quadrivalent Human Papillomavirus (HPV) Vaccine: Causal or Coincidental? and this CHS article: New Research Shows How Gardasil and Cervarix Vaccines Can Silently Kill Your Daughters And Sons]

5 Nov 2012 : Column WA172

To ask Her Majesty’s Government whether they have made any assessment of the data from trials conducted by Merk on the evidence of vasculitis in those using the human papillomavirus vaccination; and, if so, what conclusions they have drawn. [HL2912]

To ask Her Majesty’s Government whether, in the light of recent research by Tomljenovic and Shaw about the safety of the human papillomavirus vaccination (HPV), they will issue guidance to doctors and immunisation nurses about the recording of adverse medical events following the administration of the HPV and the conduct of studies on those receiving the vaccination.[HL2913]

To ask Her Majesty’s Government what criteria they use to assess whether a vaccine should be withdrawn from use; and whether they plan to test the human papillomavirus vaccination against those criteria.[HL2914]

To ask Her Majesty’s Government what assessment they have made of the adequacy of surrogate marker-based extrapolations in demonstrating the efficacy of the human papillomavirus vaccination against cervical cancer.[HL2915]

Read the official response here.

Speak Your Mind

*

*